Hepion Pharmaceuticals, Inc.
HEPA
$0.0642
-$0.0014-2.13%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -26.93% | -29.85% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.86% | 6.52% | |||
| Operating Income | -4.86% | -6.52% | |||
| Income Before Tax | 82.92% | -294.57% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 82.92% | -294.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 82.92% | -294.57% | |||
| EBIT | -4.86% | -6.52% | |||
| EBITDA | -4.89% | -5.88% | |||
| EPS Basic | 95.73% | 80.62% | |||
| Normalized Basic EPS | 74.34% | 97.55% | |||
| EPS Diluted | 95.73% | 80.62% | |||
| Normalized Diluted EPS | 74.34% | 97.55% | |||
| Average Basic Shares Outstanding | 299.34% | 1,936.40% | |||
| Average Diluted Shares Outstanding | 299.34% | 1,936.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||